{"id":"W4200101750","doi":"10.1182/bloodadvances.2021005240","title":"Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Oncology; Risk analysis (engineering); Risk assessment; Myelodysplastic syndromes; Internal medicine; Intensive care medicine; Computer science; Cancer; Computer security; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009216159,0.0003185342,0.0009900121,0.0002290966,0.0001144987,0.0004302125,0.0002803801,0.0003646059,0.001243538],"category_scores_gemma":[0.0007892106,0.0001215414,0.0005807193,0.0001865914,0.0002341952,0.0003169704,0.0001906669,0.0009077806,0.0002087867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002491755,"about_ca_system_score_gemma":0.0002800091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001505714,"about_ca_topic_score_gemma":0.0009189642,"domain_scores_codex":[0.9996238,0.0001730713,0.00004123243,0.00004680363,0.00007222252,0.00004286407],"domain_scores_gemma":[0.9994697,0.0001876588,0.0001351376,0.00005667012,0.00003585252,0.0001149984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1576779,0.006872636,0.06736565,0.001069527,0.003100945,0.001594064,0.0001962317,0.006237769,0.2559428,0.0006005378,0.002679033,0.4966629],"study_design_scores_gemma":[0.07120569,0.5722869,0.249411,0.0001483073,0.00484928,0.008037154,0.0001632442,0.009468506,0.05955288,0.0009317052,0.0238387,0.0001066408],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934704,0.004519738,0.0004482948,0.0002397738,0.00004775149,0.00005133331,0.0001995435,0.00001885055,0.001004236],"genre_scores_gemma":[0.9975223,0.0009414,0.0004627187,0.000186762,0.00006854744,0.00002349849,0.0003969309,0.000006034393,0.0003918729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001243538,"threshold_uncertainty_score":0.004874051,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01540673069825848,"score_gpt":0.2841526436120235,"score_spread":0.268745912913765,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}